Aspect Biosystems

Tamer Mohamed, CEO
Vancouver, Canada
(Private)
Aspect Biosystems is a privately-held biotechnology platform company pioneering the microfluidic 3D bioprinting of human tissues. The Company’s proprietary technology has the potential to shape every aspect of human health by enabling the creation of human tissues for medical research, therapeutic discovery, and regenerative medicine. Aspect is focused on partnering with academic institutions and biopharma companies to facilitate high-value discovery and development. The Company is also advancing internal tissue therapeutic programs for regenerative medicine, with an initial focus on metabolic diseases, and musculoskeletal injuries and disorders.
www.aspectbiosystems.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions